Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
Toshimasa Yamauchi(The University of Tokyo), Takashi Kadowaki(Toranomon Hospital), Philippe Froguel(European Genomic Institute for Diabetes), Barbara B. Kahn(Beth Israel Deaconess Medical Center), Hironori Waki(Akita University), Yusuke Ito(Institute for Advanced Medical Research), Mitsuhiko Noda(International University of Health and Welfare), Satoshi Yamashita(National Center For Child Health and Development), Satoshi Kimura(Showa University Northern Yokohama Hospital), Fabienne Foufelle(Inserm), Shunbun Kita(The University of Tokyo), Kazuhiro Eto(Japan Science and Technology Agency), Pascal Ferré(Inserm), Kohjiro Ueki(Institute for Security Studies), Y Akanuma(Japan Science and Technology Agency), Shoko Uchida(The University of Tokyo), Junji Kamon(The University of Tokyo), Yasuhiko Minokoshi(National Institute for Physiological Sciences), R Nagai(The University of Tokyo), David Carling(Hammersmith Hospital)
Cited by 4,223
Related Papers
Obesity and insulin resistance
|Journal of Clinical Investigation|2000|3.2k
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
|Cell Metabolism|2005|2.8k
Adiponectin and Adiponectin Receptors
|Endocrine Reviews|2005|2.6k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k